DuPont de Nemours, Inc.

WBAG:DDPN Stock Report

Market Cap: €30.3b

DuPont de Nemours Valuation

Is DDPN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of DDPN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: DDPN (€72.78) is trading below our estimate of fair value (€149.44)

Significantly Below Fair Value: DDPN is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for DDPN?

Key metric: As DDPN is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for DDPN. This is calculated by dividing DDPN's market cap by their current earnings.
What is DDPN's PE Ratio?
PE Ratio61.5x
EarningsUS$508.00m
Market CapUS$31.24b

Price to Earnings Ratio vs Peers

How does DDPN's PE Ratio compare to its peers?

The above table shows the PE ratio for DDPN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average23.7x
PPG PPG Industries
17.8x7.4%US$26.5b
600309 Wanhua Chemical Group
14.5x18.8%CN¥220.1b
GIVN Givaudan
35.3x6.1%CHF 36.4b
SIKA Sika
27.4x7.8%CHF 34.2b
DDPN DuPont de Nemours
61.5x23.7%€31.2b

Price-To-Earnings vs Peers: DDPN is expensive based on its Price-To-Earnings Ratio (61.5x) compared to the peer average (23.7x).


Price to Earnings Ratio vs Industry

How does DDPN's PE Ratio compare vs other companies in the European Chemicals Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
DDPN 61.5xIndustry Avg. 17.0xNo. of Companies11PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: DDPN is expensive based on its Price-To-Earnings Ratio (61.5x) compared to the European Chemicals industry average (17x).


Price to Earnings Ratio vs Fair Ratio

What is DDPN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

DDPN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio61.5x
Fair PE Ratio30.3x

Price-To-Earnings vs Fair Ratio: DDPN is expensive based on its Price-To-Earnings Ratio (61.5x) compared to the estimated Fair Price-To-Earnings Ratio (30.3x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst DDPN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€72.78
€93.42
+28.4%
16.2%€113.03€42.87n/a16
Dec ’25€79.57
€91.58
+15.1%
13.2%€102.08€49.61n/a16
Nov ’25€76.21
€87.64
+15.0%
13.2%€97.27€48.17n/a17
Oct ’25€79.69
€83.67
+5.0%
13.2%€94.04€46.57n/a17
Sep ’25€75.44
€84.69
+12.3%
13.1%€95.49€47.29n/a17
Aug ’25€76.02
€85.32
+12.2%
13.0%€97.30€48.19n/a17
Jul ’25€73.85
€83.12
+12.6%
13.1%€95.37€48.15n/a17
Jun ’25€74.66
€83.12
+11.3%
13.1%€95.37€48.15n/a17
May ’25€68.42
€74.59
+9.0%
11.9%€84.18€48.64n/a16
Apr ’25€71.10
€70.27
-1.2%
13.3%€92.54€48.12n/a16
Mar ’25€64.32
€70.39
+9.4%
13.0%€93.38€48.56n/a16
Feb ’25€56.76
€70.17
+23.6%
13.4%€92.33€48.01n/a16
Jan ’25€69.64
€72.77
+4.5%
12.4%€83.62€44.54€73.5016
Dec ’24€66.56
€71.63
+7.6%
12.8%€83.75€44.60€79.5716
Nov ’24€64.22
€74.83
+16.5%
14.8%€87.06€46.37€76.2117
Oct ’24€71.14
€76.32
+7.3%
12.6%€86.10€45.86€79.6917
Sep ’24€71.98
€74.75
+3.9%
12.3%€84.08€44.78€75.4418
Aug ’24€70.54
€70.47
-0.09%
11.9%€82.93€44.17€76.0218
Jul ’24€65.50
€70.53
+7.7%
12.4%€84.36€47.68€73.8519
Jun ’24€63.26
€72.27
+14.2%
12.6%€86.08€48.66€74.6618
May ’24€61.60
€76.37
+24.0%
12.6%€94.23€47.57€68.4217
Apr ’24€65.90
€77.24
+17.2%
12.8%€94.44€47.68€71.1017
Mar ’24€69.20
€79.73
+15.2%
14.0%€97.63€42.66€64.3218
Feb ’24€67.39
€73.60
+9.2%
14.8%€94.39€41.24€56.7619
Jan ’24€64.23
€75.04
+16.8%
14.8%€97.19€42.46€69.6419

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 03:21
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

DuPont de Nemours, Inc. is covered by 46 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
William SeleskyArgus Research Company
Colin IsaacAtlantic Equities LLP
Patrick Duffy FischerBarclays